NCT04223856 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 442
- group Id
- BG001
- value
- 444
- group Id
- BG002
- value
- 886
- units
- Participants
- groups
- description
- Participants received enfortumab vedotin at 1.25 mg/kg as an IV infusion over approximately 30 minutes on Days 1 and 8 of each cycle, and pembrolizumab 200 mg as an IV infusion over approximately 30 minutes on Day 1 of each cycle, after completion of the enfortumab vedotin infusion. 1 cycle = 3 weeks.
- id
- BG000
- title
- Enfortumab Vedotin + Pembrolizumab
- description
- Participants received gemcitabine at 1000 mg/m\^2 as an IV infusion on Days 1 and 8 of each cycle, and either cisplatin (70 mg/m\^2) or carboplatin (AUC 4.5, or AUC 5 according to local guidelines) on Day 1 of each cycle, with adequate pre- and post-hydration, by IV infusion per institutional standards. 1 cycle = 3 weeks.
- id
- BG001
- title
- Standard of Care
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.1
- value
- 67.9
- group Id
- BG001
- spread
- 9.4
- value
- 68.0
- group Id
- BG002
- spread
- 9.2
- value
- 67.9
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 98
- group Id
- BG001
- value
- 108
- group Id
- BG002
- value
- 206
- title
- Female
- measurements
- group Id
- BG000
- value
- 344
- group Id
- BG001
- value
- 336
- group Id
- BG002
- value
- 680
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 52
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 104
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 359
- group Id
- BG001
- value
- 343
- group Id
- BG002
- value
- 702
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 31
- group Id
- BG001
- value
- 49
- group Id
- BG002
- value
- 80
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 4
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 99
- group Id
- BG001
- value
- 92
- group Id
- BG002
- value
- 191
- title
- Asian
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 10
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 308
- group Id
- BG001
- value
- 290
- group Id
- BG002
- value
- 598
- title
- White
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 4
- title
- Other
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 4
- title
- Multiple
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 15
- title
- Unknown
- measurements
- group Id
- BG000
- value
- 22
- group Id
- BG001
- value
- 37
- group Id
- BG002
- value
- 59
- title
- Not Reported
- title
- Race
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- population Description
- Intent-to-Treat (ITT) analysis set include all randomized participants. Participants were analyzed according to the treatment arm assigned at randomization regardless of the actual treatment received.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 442
- group Id
- BG001
- value
- 444
- group Id
- BG002
- value
- 886
- units
- Participants
- groups
- description
- Participants received enfortumab vedotin at 1.25 mg/kg as an IV infusion over approximately 30 minutes on Days 1 and 8 of each cycle, and pembrolizumab 200 mg as an IV infusion over approximately 30 minutes on Day 1 of each cycle, after completion of the enfortumab vedotin infusion. 1 cycle = 3 weeks.
- id
- BG000
- title
- Enfortumab Vedotin + Pembrolizumab
- description
- Participants received gemcitabine at 1000 mg/m\^2 as an IV infusion on Days 1 and 8 of each cycle, and either cisplatin (70 mg/m\^2) or carboplatin (AUC 4.5, or AUC 5 according to local guidelines) on Day 1 of each cycle, with adequate pre- and post-hydration, by IV infusion per institutional standards. 1 cycle = 3 weeks.
- id
- BG001
- title
- Standard of Care
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.1
- value
- 67.9
- group Id
- BG001
- spread
- 9.4
- value
- 68.0
- group Id
- BG002
- spread
- 9.2
- value
- 67.9
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 98
- group Id
- BG001
- value
- 108
- group Id
- BG002
- value
- 206
- title
- Female
- measurements
- group Id
- BG000
- value
- 344
- group Id
- BG001
- value
- 336
- group Id
- BG002
- value
- 680
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 52
- group Id
- BG001
- value
- 52
- group Id
- BG002
- value
- 104
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 359
- group Id
- BG001
- value
- 343
- group Id
- BG002
- value
- 702
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 31
- group Id
- BG001
- value
- 49
- group Id
- BG002
- value
- 80
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 4
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 99
- group Id
- BG001
- value
- 92
- group Id
- BG002
- value
- 191
- title
- Asian
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 10
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 308
- group Id
- BG001
- value
- 290
- group Id
- BG002
- value
- 598
- title
- White
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 4
- title
- Other
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 4
- title
- Multiple
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 15
- title
- Unknown
- measurements
- group Id
- BG000
- value
- 22
- group Id
- BG001
- value
- 37
- group Id
- BG002
- value
- 59
- title
- Not Reported
- title
- Race
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- population Description
- Intent-to-Treat (ITT) analysis set include all randomized participants. Participants were analyzed according to the treatment arm assigned at randomization regardless of the actual treatment received.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle